Serveur d'exploration sur les mitochondries dans l'oxydoréduction chez les plantes

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Acerola polysaccharides ameliorate high-fat diet-induced non-alcoholic fatty liver disease through reduction of lipogenesis and improvement of mitochondrial functions in mice.

Identifieur interne : 000060 ( Main/Exploration ); précédent : 000059; suivant : 000061

Acerola polysaccharides ameliorate high-fat diet-induced non-alcoholic fatty liver disease through reduction of lipogenesis and improvement of mitochondrial functions in mice.

Auteurs : Yuanyuan Hu [République populaire de Chine] ; Fawen Yin ; Zhongyuan Liu ; Hongkai Xie ; Yunsheng Xu ; Dayong Zhou ; Beiwei Zhu

Source :

RBID : pubmed:31819934

Descripteurs français

English descriptors

Abstract

Acerola polysaccharides (ACPs) were purified from acerola (Malpighia emarginata DC.), a tropical fruit with strong antioxidant and anti-inflammatory activities. However, the biological activities of ACPs have barely been investigated. The present study was designed to investigate the efficacy of ACPs in the treatment of high-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD) in C57BL/6 mice. Male C57BL/6 mice were fed with a high-fat diet and treated with different doses of ACPs for 9 continuous weeks. NAFLD was examined in terms of body weight, lipid profiles, liver function markers, and histology. Gene expression was determined by using both qRT-PCR and western blot. Our results showed that administration of ACPs significantly reduced HFD-induced hyperlipidemia and hepatic lipid deposition by inhibiting the SREBP1c pathway in mice. ACP treatment normalized oxidative stress by activating nuclear factor (erythroid-derived-2)-like 2 (Nrf2) and reduced the expressions of pro-inflammatory cytokines in HFD fed mice. Furthermore, ACPs reduced uncoupling protein 2 (UCP2) expression, restored mitochondrial ATP content, increased mitochondrial complex I, IV, and V activity, and increased mitochondrial beta-oxidation by stimulating peroxisomal proliferator-activated receptor-gamma coactivator-1α (PGC-1α) in the liver of HFD-fed mice. Our study indicated that ACPs may be an effective dietary supplement for preventing HFD-induced NAFLD by regulating lipogenesis, reducing inflammation and oxidative stress, and promoting the mitochondrial function.

DOI: 10.1039/c9fo01611b
PubMed: 31819934


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Acerola polysaccharides ameliorate high-fat diet-induced non-alcoholic fatty liver disease through reduction of lipogenesis and improvement of mitochondrial functions in mice.</title>
<author>
<name sortKey="Hu, Yuanyuan" sort="Hu, Yuanyuan" uniqKey="Hu Y" first="Yuanyuan" last="Hu">Yuanyuan Hu</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Food Science and Technology, Dalian Polytechnic University, Dalian, 116034, PR China. zdyzf1@163.com.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Food Science and Technology, Dalian Polytechnic University, Dalian, 116034</wicri:regionArea>
<wicri:noRegion>116034</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yin, Fawen" sort="Yin, Fawen" uniqKey="Yin F" first="Fawen" last="Yin">Fawen Yin</name>
</author>
<author>
<name sortKey="Liu, Zhongyuan" sort="Liu, Zhongyuan" uniqKey="Liu Z" first="Zhongyuan" last="Liu">Zhongyuan Liu</name>
</author>
<author>
<name sortKey="Xie, Hongkai" sort="Xie, Hongkai" uniqKey="Xie H" first="Hongkai" last="Xie">Hongkai Xie</name>
</author>
<author>
<name sortKey="Xu, Yunsheng" sort="Xu, Yunsheng" uniqKey="Xu Y" first="Yunsheng" last="Xu">Yunsheng Xu</name>
</author>
<author>
<name sortKey="Zhou, Dayong" sort="Zhou, Dayong" uniqKey="Zhou D" first="Dayong" last="Zhou">Dayong Zhou</name>
</author>
<author>
<name sortKey="Zhu, Beiwei" sort="Zhu, Beiwei" uniqKey="Zhu B" first="Beiwei" last="Zhu">Beiwei Zhu</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:31819934</idno>
<idno type="pmid">31819934</idno>
<idno type="doi">10.1039/c9fo01611b</idno>
<idno type="wicri:Area/Main/Corpus">000054</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000054</idno>
<idno type="wicri:Area/Main/Curation">000054</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000054</idno>
<idno type="wicri:Area/Main/Exploration">000054</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Acerola polysaccharides ameliorate high-fat diet-induced non-alcoholic fatty liver disease through reduction of lipogenesis and improvement of mitochondrial functions in mice.</title>
<author>
<name sortKey="Hu, Yuanyuan" sort="Hu, Yuanyuan" uniqKey="Hu Y" first="Yuanyuan" last="Hu">Yuanyuan Hu</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Food Science and Technology, Dalian Polytechnic University, Dalian, 116034, PR China. zdyzf1@163.com.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Food Science and Technology, Dalian Polytechnic University, Dalian, 116034</wicri:regionArea>
<wicri:noRegion>116034</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yin, Fawen" sort="Yin, Fawen" uniqKey="Yin F" first="Fawen" last="Yin">Fawen Yin</name>
</author>
<author>
<name sortKey="Liu, Zhongyuan" sort="Liu, Zhongyuan" uniqKey="Liu Z" first="Zhongyuan" last="Liu">Zhongyuan Liu</name>
</author>
<author>
<name sortKey="Xie, Hongkai" sort="Xie, Hongkai" uniqKey="Xie H" first="Hongkai" last="Xie">Hongkai Xie</name>
</author>
<author>
<name sortKey="Xu, Yunsheng" sort="Xu, Yunsheng" uniqKey="Xu Y" first="Yunsheng" last="Xu">Yunsheng Xu</name>
</author>
<author>
<name sortKey="Zhou, Dayong" sort="Zhou, Dayong" uniqKey="Zhou D" first="Dayong" last="Zhou">Dayong Zhou</name>
</author>
<author>
<name sortKey="Zhu, Beiwei" sort="Zhu, Beiwei" uniqKey="Zhu B" first="Beiwei" last="Zhu">Beiwei Zhu</name>
</author>
</analytic>
<series>
<title level="j">Food & function</title>
<idno type="eISSN">2042-650X</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals (MeSH)</term>
<term>Antioxidants (pharmacology)</term>
<term>Diet, High-Fat (adverse effects)</term>
<term>Lipogenesis (MeSH)</term>
<term>Male (MeSH)</term>
<term>Malpighiaceae (chemistry)</term>
<term>Mice (MeSH)</term>
<term>Mice, Inbred C57BL (MeSH)</term>
<term>Mitochondria (metabolism)</term>
<term>Non-alcoholic Fatty Liver Disease (metabolism)</term>
<term>Non-alcoholic Fatty Liver Disease (therapy)</term>
<term>Oxidation-Reduction (MeSH)</term>
<term>Oxidative Stress (drug effects)</term>
<term>Polysaccharides (pharmacology)</term>
<term>Sterol Regulatory Element Binding Protein 1 (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Alimentation riche en graisse (effets indésirables)</term>
<term>Animaux (MeSH)</term>
<term>Antioxydants (pharmacologie)</term>
<term>Lipogenèse (MeSH)</term>
<term>Malpighiaceae (composition chimique)</term>
<term>Mitochondries (métabolisme)</term>
<term>Mâle (MeSH)</term>
<term>Oxydoréduction (MeSH)</term>
<term>Polyosides (pharmacologie)</term>
<term>Protéine-1 de liaison à l'élément de régulation des stérols (métabolisme)</term>
<term>Souris (MeSH)</term>
<term>Souris de lignée C57BL (MeSH)</term>
<term>Stress oxydatif (effets des médicaments et des substances chimiques)</term>
<term>Stéatose hépatique non alcoolique (métabolisme)</term>
<term>Stéatose hépatique non alcoolique (thérapie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Sterol Regulatory Element Binding Protein 1</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antioxidants</term>
<term>Polysaccharides</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Diet, High-Fat</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Malpighiaceae</term>
</keywords>
<keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr">
<term>Malpighiaceae</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Oxidative Stress</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Stress oxydatif</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Alimentation riche en graisse</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Mitochondria</term>
<term>Non-alcoholic Fatty Liver Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Mitochondries</term>
<term>Protéine-1 de liaison à l'élément de régulation des stérols</term>
<term>Stéatose hépatique non alcoolique</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antioxydants</term>
<term>Polyosides</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Non-alcoholic Fatty Liver Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr">
<term>Stéatose hépatique non alcoolique</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Lipogenesis</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Oxidation-Reduction</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Lipogenèse</term>
<term>Mâle</term>
<term>Oxydoréduction</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Acerola polysaccharides (ACPs) were purified from acerola (Malpighia emarginata DC.), a tropical fruit with strong antioxidant and anti-inflammatory activities. However, the biological activities of ACPs have barely been investigated. The present study was designed to investigate the efficacy of ACPs in the treatment of high-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD) in C57BL/6 mice. Male C57BL/6 mice were fed with a high-fat diet and treated with different doses of ACPs for 9 continuous weeks. NAFLD was examined in terms of body weight, lipid profiles, liver function markers, and histology. Gene expression was determined by using both qRT-PCR and western blot. Our results showed that administration of ACPs significantly reduced HFD-induced hyperlipidemia and hepatic lipid deposition by inhibiting the SREBP1c pathway in mice. ACP treatment normalized oxidative stress by activating nuclear factor (erythroid-derived-2)-like 2 (Nrf2) and reduced the expressions of pro-inflammatory cytokines in HFD fed mice. Furthermore, ACPs reduced uncoupling protein 2 (UCP2) expression, restored mitochondrial ATP content, increased mitochondrial complex I, IV, and V activity, and increased mitochondrial beta-oxidation by stimulating peroxisomal proliferator-activated receptor-gamma coactivator-1α (PGC-1α) in the liver of HFD-fed mice. Our study indicated that ACPs may be an effective dietary supplement for preventing HFD-induced NAFLD by regulating lipogenesis, reducing inflammation and oxidative stress, and promoting the mitochondrial function.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">31819934</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>10</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>10</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2042-650X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2020</Year>
<Month>Jan</Month>
<Day>29</Day>
</PubDate>
</JournalIssue>
<Title>Food & function</Title>
<ISOAbbreviation>Food Funct</ISOAbbreviation>
</Journal>
<ArticleTitle>Acerola polysaccharides ameliorate high-fat diet-induced non-alcoholic fatty liver disease through reduction of lipogenesis and improvement of mitochondrial functions in mice.</ArticleTitle>
<Pagination>
<MedlinePgn>1037-1048</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1039/c9fo01611b</ELocationID>
<Abstract>
<AbstractText>Acerola polysaccharides (ACPs) were purified from acerola (Malpighia emarginata DC.), a tropical fruit with strong antioxidant and anti-inflammatory activities. However, the biological activities of ACPs have barely been investigated. The present study was designed to investigate the efficacy of ACPs in the treatment of high-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD) in C57BL/6 mice. Male C57BL/6 mice were fed with a high-fat diet and treated with different doses of ACPs for 9 continuous weeks. NAFLD was examined in terms of body weight, lipid profiles, liver function markers, and histology. Gene expression was determined by using both qRT-PCR and western blot. Our results showed that administration of ACPs significantly reduced HFD-induced hyperlipidemia and hepatic lipid deposition by inhibiting the SREBP1c pathway in mice. ACP treatment normalized oxidative stress by activating nuclear factor (erythroid-derived-2)-like 2 (Nrf2) and reduced the expressions of pro-inflammatory cytokines in HFD fed mice. Furthermore, ACPs reduced uncoupling protein 2 (UCP2) expression, restored mitochondrial ATP content, increased mitochondrial complex I, IV, and V activity, and increased mitochondrial beta-oxidation by stimulating peroxisomal proliferator-activated receptor-gamma coactivator-1α (PGC-1α) in the liver of HFD-fed mice. Our study indicated that ACPs may be an effective dietary supplement for preventing HFD-induced NAFLD by regulating lipogenesis, reducing inflammation and oxidative stress, and promoting the mitochondrial function.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hu</LastName>
<ForeName>Yuanyuan</ForeName>
<Initials>Y</Initials>
<Suffix></Suffix>
<AffiliationInfo>
<Affiliation>School of Food Science and Technology, Dalian Polytechnic University, Dalian, 116034, PR China. zdyzf1@163.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yin</LastName>
<ForeName>Fawen</ForeName>
<Initials>F</Initials>
<Suffix></Suffix>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Zhongyuan</ForeName>
<Initials>Z</Initials>
<Suffix></Suffix>
</Author>
<Author ValidYN="Y">
<LastName>Xie</LastName>
<ForeName>Hongkai</ForeName>
<Initials>H</Initials>
<Suffix></Suffix>
</Author>
<Author ValidYN="Y">
<LastName>Xu</LastName>
<ForeName>Yunsheng</ForeName>
<Initials>Y</Initials>
<Suffix></Suffix>
</Author>
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Dayong</ForeName>
<Initials>D</Initials>
<Suffix></Suffix>
</Author>
<Author ValidYN="Y">
<LastName>Zhu</LastName>
<ForeName>Beiwei</ForeName>
<Initials>B</Initials>
<Suffix></Suffix>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Food Funct</MedlineTA>
<NlmUniqueID>101549033</NlmUniqueID>
<ISSNLinking>2042-6496</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011134">Polysaccharides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051780">Sterol Regulatory Element Binding Protein 1</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D059305" MajorTopicYN="N">Diet, High-Fat</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D050155" MajorTopicYN="Y">Lipogenesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D029581" MajorTopicYN="N">Malpighiaceae</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D065626" MajorTopicYN="N">Non-alcoholic Fatty Liver Disease</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011134" MajorTopicYN="N">Polysaccharides</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051780" MajorTopicYN="N">Sterol Regulatory Element Binding Protein 1</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>12</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>10</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>12</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">31819934</ArticleId>
<ArticleId IdType="doi">10.1039/c9fo01611b</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Liu, Zhongyuan" sort="Liu, Zhongyuan" uniqKey="Liu Z" first="Zhongyuan" last="Liu">Zhongyuan Liu</name>
<name sortKey="Xie, Hongkai" sort="Xie, Hongkai" uniqKey="Xie H" first="Hongkai" last="Xie">Hongkai Xie</name>
<name sortKey="Xu, Yunsheng" sort="Xu, Yunsheng" uniqKey="Xu Y" first="Yunsheng" last="Xu">Yunsheng Xu</name>
<name sortKey="Yin, Fawen" sort="Yin, Fawen" uniqKey="Yin F" first="Fawen" last="Yin">Fawen Yin</name>
<name sortKey="Zhou, Dayong" sort="Zhou, Dayong" uniqKey="Zhou D" first="Dayong" last="Zhou">Dayong Zhou</name>
<name sortKey="Zhu, Beiwei" sort="Zhu, Beiwei" uniqKey="Zhu B" first="Beiwei" last="Zhu">Beiwei Zhu</name>
</noCountry>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Hu, Yuanyuan" sort="Hu, Yuanyuan" uniqKey="Hu Y" first="Yuanyuan" last="Hu">Yuanyuan Hu</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/MitoPlantRedoxV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000060 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000060 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    MitoPlantRedoxV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:31819934
   |texte=   Acerola polysaccharides ameliorate high-fat diet-induced non-alcoholic fatty liver disease through reduction of lipogenesis and improvement of mitochondrial functions in mice.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:31819934" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MitoPlantRedoxV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat Nov 21 12:18:52 2020. Site generation: Sat Nov 21 12:19:22 2020